- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04364854
Speech Entrainment for Aphasia Recovery (SpARc)
After a stroke, many people experience a language impairment called aphasia. One of the most debilitating types of aphasia is non-fluent aphasia. Non-fluent aphasia is defined by significantly reduced speech production, with the speaker producing only a few words or even less. Speech entrainment therapy (SET) is a treatment that has been shown to increase fluency in people with non-fluent aphasia. The study looks to define the best dose of SET that leads to sustained improvements in spontaneous speech production.
Participants who are eligible will undergo baseline language testing, an MRI, and will be randomized into one of 4 treatment groups: SET for 3 weeks, SET for 4.5 weeks, SET for 6 weeks, and no treatment (control group).
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Kelly Krajeck, MHA
- Phone Number: (843) 792-0189
- Email: krajeck@musc.edu
Study Contact Backup
- Name: Stephanie Cute, CCC-SLP
- Phone Number: (843) 792-3678
- Email: cute@musc.edu
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29401
- Recruiting
- Medical University of South Carolina
-
Principal Investigator:
- Janina Wilmskoetter, PhD
-
Contact:
- Stephanie Cute, CCC-SLP
- Phone Number: 843-792-3678
- Email: cute@musc.edu
-
Columbia, South Carolina, United States, 29208
- Recruiting
- University of South Carolina
-
Contact:
- Mary Aitchison, PhD
- Phone Number: 803-777-5905
- Email: mjaitchi@mailbox.sc.edu
-
Principal Investigator:
- Julius Fridriksson, PhD
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- Recruiting
- University of Utah
-
Contact:
- Julie Wambaugh, PhD
- Phone Number: 801-585-6164
- Email: julie.wambaugh@health.utah.edu
-
Principal Investigator:
- Robert Kraemer, PhD
-
Principal Investigator:
- Julie Wambaugh, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria
- Aphasia as a result of a left hemisphere ischemic or hemorrhagic stroke (WAB-R Aphasia Quotient <93.8).
- Presence of left hemisphere stroke in clinical imaging (CT/MRI) and NIHSS
- Participants must have spoken English as their primary language.
- 21-81 years old
- Pre-stroke modified Rankin Scale (mRS)= 2 or less
- Post-stroke mRS= 4 or less.
- At least 6 months post-stroke.
- Non-fluent aphasia (WAB-R Comprehension score >4 and WAB-R Fluency score <6).
- Technological compatibility (to be determined by clinical judgment of SLP)
Exclusion Criteria
- History of chronic neurological or psychiatric diseases (excluding migraines, depression, or post-stroke epilepsy). Self-reported history of learning disability.
- Severe dysarthria (determined via SLP clinical judgment from spontaneous speech tasks on the ASRS 3.0).
- Global aphasia.
- History of right-hemisphere strokes or brain stem/cerebellar strokes with persistent deficits (as evidenced by MRI/CT and NIHSS).
- Uncorrectable hearing as determined by the SLP's clinical judgment.
- Uncorrectable vision.
- Contraindications to MRI or inability to complete the MRI scanning session.
- Women who are pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SET (Speech Entrainment Therapy) 3 weeks
|
3 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
|
Experimental: SET (Speech Entrainment Therapy) 4.5 weeks
|
4.5 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
|
Experimental: SET (Speech Entrainment Therapy) 6 weeks
|
6 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
|
Other: No Therapy 6 weeks
|
Participants will not be getting any SET for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Verbs Per Minute (VPM) in Speech Sample
Time Frame: 3 months after treatment (or no treatment)
|
VPM will be assessed through procedural storytelling and narrative story telling tasks - with four items in each category. The procedural storytelling items are: 1) how to make a peanut butter and jelly sandwich, 2) how to make scrambled eggs, 3) how to brew coffee, and 4) how to wash dishes. The narrative items will be: 1) Cinderella story, 2) Little Red Riding Hood, 3) The Three Little Pigs, and 4) Goldilocks. |
3 months after treatment (or no treatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)
Time Frame: 3 months after treatment (or no treatment)
|
We will estimate the dose of SET for individuals with non-fluent aphasia that has the highest effect size on SAQOL-39g.
|
3 months after treatment (or no treatment)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Leonardo Bonilha, MD, PhD, Emory University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00091924
- U01DC017521-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on SET (Speech Entrainment Therapy) 3 weeks
-
Weill Medical College of Cornell UniversityRecruitingBreast CancerUnited States
-
Jordan Miller, Graduate StudentPhysiotherapy Foundation of CanadaCompletedResponses of People With Neck Pain Being Treated With Varying Doses of Manual Therapy: A Pilot StudyWhiplash InjuriesCanada
-
Hams Hamed AbdelrahmanActive, not recruiting
-
Johns Hopkins All Children's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedVenous ThrombosisUnited States, Australia, Canada, Austria, Israel, Netherlands
-
Tourcoing HospitalNot yet recruiting
-
St. John Health System, OklahomaUnknownMalnutrition | GastrostomyUnited States
-
Karolinska InstitutetKarolinska University Hospital; Medical University of Graz; Medical University... and other collaboratorsUnknown
-
Hadassah Medical OrganizationCompletedMetastatic Breast Cancer | Gastrointestinal Cancer | Renal Cell Cancer | Malignant MelanomaIsrael
-
Jiandong ZhangRecruiting
-
Mayo ClinicTerminatedHead and Neck CancerUnited States